Mayne Pharma Group Ltd DistributeRx US Launch Webinar Transcript
Thank you, Harmony, and thank you, everyone, for joining today's call with Mayne Pharma and DistributeRx executives. It's certainly an exciting period for Mayne Pharma with the launch of DistributeRx this week as announced on ASX yesterday, March 10, 2026.
If I can have the next slide, please. This is our important disclaimer. We will be making forward-looking statements on today's call. Investors are encouraged to read this disclaimer before making any form of investment decision.
Next slide, please. The agenda today is quite straightforward. We have 6 modules. I will shortly be introducing our esteemed speakers today who will then provide the background of Mayne Pharma who for those investors who are less familiar with our story and our journey thus far into our DistributeRx launch this week. We will then provide a US healthcare primer and what is the market need for a business like DistributeRx as part of overall Mayne Pharma's journey through this disintermediation process that we've been undertaking for a number of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
